Alira Health

Alira Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Alira Health is a privately held, Boston-based consultancy and CRO founded in 2015, serving the global life sciences industry. The company differentiates itself through a strong patient-centric ethos, integrating traditional advisory and clinical trial services with its proprietary Health Storylines™ patient engagement platform. It has established a significant client base, including a majority of the top 50 pharma and MedTech companies, and focuses on therapeutic areas such as autoimmune diseases, nuclear medicine, and wound care. Alira Health operates as a full-service partner, aiming to bridge clinical research with routine care to improve patient outcomes and accelerate market success for its clients.

Autoimmune DiseasesNuclear MedicineWound Care

Technology Platform

Health Storylines™, a next-generation patient-centric technology platform designed to capture the voice of the patient for healthcare innovation through digital patient engagement, symptom tracking, and data collection.

Funding History

2
Total raised:$10M
UndisclosedUndisclosed
Series A$10M

Opportunities

The growing emphasis on patient-centric drug development and real-world evidence generation creates strong demand for Alira Health's integrated model and Health Storylines platform.
Specialization in complex, high-growth areas like nuclear medicine and advanced wound care provides a defensible niche against larger generalist competitors.

Risk Factors

Intense competition from large, well-resourced global CROs and consulting firms poses a constant challenge.
The business is also exposed to cyclical fluctuations in biopharma R&D spending and execution risk on complex, integrated service contracts.

Competitive Landscape

Alira Health competes in the crowded life sciences consulting and CRO market against giants like IQVIA, ICON, and Parexel, as well as management consultancies. It differentiates through a strong patient-centric ethos, integrated service-technology offerings, and deep expertise in niche therapeutic areas like nuclear medicine.